PDMP Rules

Oregon's Prescription Drug Monitoring Rules

The Oregon Health Authority, Public Health Division is proposing to permanently adopt and amend administrative rules in chapter 333, division 23 pertaining to the Prescription Drug Monitoring Program (PDMP). House Bill 4143 (Oregon Laws 2018, chapter 45), passed during the 2018 legislative session, requires all practitioners in Oregon to register with the PDMP. Permanent adoption of OAR 333-023-0825, which was adopted temporarily on April 5, 2018, will allow the Oregon Health Authority to remove unnecessary burden on practitioners while preserving legislative intent. This includes clarifying the conditions under which a practitioner is required to register.

Additional rules in division 23 will also be updated to reflect changes in the program that have taken place since permanent rulemaking was last completed. These changes include adding new values collected and displayed in the PDMP, and PDMP access being granted to medical and pharmacy directors for the purpose of overseeing the operations of their respective entities.  

Public is invited to review and comment on the proposed rules. If you wish to present oral testimony, a public hearing will be held in Portland, Oregon at 800 NE Oregon St, Room 1C, on June 19, 2018 at 1:30 p.m. You may also file written comments before 5:00 p.m. on June 22, 2018 by submitting them to the Public Health Division Rules Coordinator at the following address:

OHA, Public Health Division
Brittany Hall, Administrative Rules Coordinator
800 NE Oregon Street, Suite 930
Portland, Oregon 97232
E-mail comments to: publichealth.rules@state.or.us

You may also send comments by fax to (971) 673-1299.

Final rules will be filed after consideration of all comments.

For more details, please see the Notice of Proposed Rulemaking Hearing

 

Prescription Drug Monitoring Program Rules

 

Temporary Rule: 
Requirements for practitioners to register with the Prescription Drug Monitoring Program
EFFECTIVE DATE: 04/05/2018 

 
 
 
 

© 2018 Appriss Health, All rights reserved.

Prescription Drug Monitoring Program - IPE | PO Box 14450

Portland, OR 97293-0450 Phone: 971-673-0741 | Fax: 971-673-0990

E-mail: pdmp.health@state.or.us

TTY: 971-673-0372